Preview Mode Links will not work in preview mode

Sep 11, 2020

Featuring an interview with Dr Petros Grivas about recent advances in the use of immunotherapy for urothelial bladder cancer, including the following topics:

  • Immunotherapy for Urothelial Bladder Carcinoma — Dr Grivas (00:00)
  • Choice of first-line maintenance therapy for patients with metastatic UBC; clinical experience...


Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #1: Optimal Application of Immune Checkpoint Inhibitors in Advanced Urothelial Cancer — Dr Balar
CME information and select...


Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #2: Immune Checkpoint Inhibitors as Neoadjuvant and Adjuvant Therapy for Muscle-Invasive Bladder Cancer — Dr Daneshmand
CME information and select...


Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #3: Integrating Immune Checkpoint Inhibitors into the Current Treatment Paradigm for Non-Muscle-Invasive Bladder Cancer — Dr Kamat
CME information and select...


Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #4: Current and Future Role of Recently Approved Novel Therapies in the Management of Urothelial Bladder Carcinoma — Dr Rosenberg
CME information and select...